規制動向

FDA、EMA、TGA および世界の規制動向

#Sandoz ×

2026年8月30日•1分で読めます

FDA Approves ANDA 085702 for Phendimetrazine Tartrate Oral Capsule

Sandoz's oral capsule product PHENDIMETRAZINE TARTRATE (35 mg) under application ANDA085702 has received FDA approval; the product is listed as discontinued.

2026年8月30日•1分で読めます

FDA Discontinues Alprazolam Extended‑Release Tablets (ANDA077777)

FDA records show Sandoz's alprazolam extended‑release tablets (product numbers 001‑004) are discontinued, with multiple labeling supplement approvals.